COVID-19 Impact on Global Hunter Syndrome Treatment Market Size, Status and Forecast 2020-2026

August 2020 | 99 pages | ID: C0FD3EF56CE3EN
QYResearch

Abstracts

This report focuses on the global Hunter Syndrome Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Hunter Syndrome Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study

• Takeda
• GC Pharma.
• JCR Pharmaceuticals Co Ltd.
• RegenxBio Inc.
• Sangamo Therapeutics, Inc.
• ArmaGen Inc.
• Inventiva S.A.
• Denali Therapeutics Inc.
• Bioasis Technologies Inc.
• Esteve

Market segment by Type, the product can be split into

• Enzyme Replacement Therapy (ERT)
• Hematopoietic Stem Cell Transplant (HSCT)
• Others

Market segment by Application, split into

• Life Science Companies
• Research Institutes
• Hospital

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Hunter Syndrome Treatment status, future forecast, growth opportunity, key market and key players.
• To present the Hunter Syndrome Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Hunter Syndrome Treatment are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Hunter Syndrome Treatment Revenue
1.4 Market Analysis by Type
  1.4.1 Global Hunter Syndrome Treatment Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Enzyme Replacement Therapy (ERT)
  1.4.3 Hematopoietic Stem Cell Transplant (HSCT)
  1.4.4 Others
1.5 Market by Application
  1.5.1 Global Hunter Syndrome Treatment Market Share by Application: 2020 VS 2026
  1.5.2 Life Science Companies
  1.5.3 Research Institutes
  1.5.4 Hospital
1.6 Coronavirus Disease 2019 (Covid-19): Hunter Syndrome Treatment Industry Impact
  1.6.1 How the Covid-19 is Affecting the Hunter Syndrome Treatment Industry
    1.6.1.1 Hunter Syndrome Treatment Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Hunter Syndrome Treatment Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Hunter Syndrome Treatment Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Hunter Syndrome Treatment Market Perspective (2015-2026)
2.2 Hunter Syndrome Treatment Growth Trends by Regions
  2.2.1 Hunter Syndrome Treatment Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Hunter Syndrome Treatment Historic Market Share by Regions (2015-2020)
  2.2.3 Hunter Syndrome Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Hunter Syndrome Treatment Market Growth Strategy
  2.3.6 Primary Interviews with Key Hunter Syndrome Treatment Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Hunter Syndrome Treatment Players by Market Size
  3.1.1 Global Top Hunter Syndrome Treatment Players by Revenue (2015-2020)
  3.1.2 Global Hunter Syndrome Treatment Revenue Market Share by Players (2015-2020)
  3.1.3 Global Hunter Syndrome Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Hunter Syndrome Treatment Market Concentration Ratio
  3.2.1 Global Hunter Syndrome Treatment Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Hunter Syndrome Treatment Revenue in 2019
3.3 Hunter Syndrome Treatment Key Players Head office and Area Served
3.4 Key Players Hunter Syndrome Treatment Product Solution and Service
3.5 Date of Enter into Hunter Syndrome Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Hunter Syndrome Treatment Historic Market Size by Type (2015-2020)
4.2 Global Hunter Syndrome Treatment Forecasted Market Size by Type (2021-2026)

5 HUNTER SYNDROME TREATMENT BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Hunter Syndrome Treatment Market Size by Application (2015-2020)
5.2 Global Hunter Syndrome Treatment Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Hunter Syndrome Treatment Market Size (2015-2020)
6.2 Hunter Syndrome Treatment Key Players in North America (2019-2020)
6.3 North America Hunter Syndrome Treatment Market Size by Type (2015-2020)
6.4 North America Hunter Syndrome Treatment Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Hunter Syndrome Treatment Market Size (2015-2020)
7.2 Hunter Syndrome Treatment Key Players in Europe (2019-2020)
7.3 Europe Hunter Syndrome Treatment Market Size by Type (2015-2020)
7.4 Europe Hunter Syndrome Treatment Market Size by Application (2015-2020)

8 CHINA

8.1 China Hunter Syndrome Treatment Market Size (2015-2020)
8.2 Hunter Syndrome Treatment Key Players in China (2019-2020)
8.3 China Hunter Syndrome Treatment Market Size by Type (2015-2020)
8.4 China Hunter Syndrome Treatment Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Hunter Syndrome Treatment Market Size (2015-2020)
9.2 Hunter Syndrome Treatment Key Players in Japan (2019-2020)
9.3 Japan Hunter Syndrome Treatment Market Size by Type (2015-2020)
9.4 Japan Hunter Syndrome Treatment Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Hunter Syndrome Treatment Market Size (2015-2020)
10.2 Hunter Syndrome Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Hunter Syndrome Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Hunter Syndrome Treatment Market Size by Application (2015-2020)

11 INDIA

11.1 India Hunter Syndrome Treatment Market Size (2015-2020)
11.2 Hunter Syndrome Treatment Key Players in India (2019-2020)
11.3 India Hunter Syndrome Treatment Market Size by Type (2015-2020)
11.4 India Hunter Syndrome Treatment Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Hunter Syndrome Treatment Market Size (2015-2020)
12.2 Hunter Syndrome Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Hunter Syndrome Treatment Market Size by Type (2015-2020)
12.4 Central & South America Hunter Syndrome Treatment Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 Takeda
  13.1.1 Takeda Company Details
  13.1.2 Takeda Business Overview and Its Total Revenue
  13.1.3 Takeda Hunter Syndrome Treatment Introduction
  13.1.4 Takeda Revenue in Hunter Syndrome Treatment Business (2015-2020))
  13.1.5 Takeda Recent Development
13.2 GC Pharma.
  13.2.1 GC Pharma. Company Details
  13.2.2 GC Pharma. Business Overview and Its Total Revenue
  13.2.3 GC Pharma. Hunter Syndrome Treatment Introduction
  13.2.4 GC Pharma. Revenue in Hunter Syndrome Treatment Business (2015-2020)
  13.2.5 GC Pharma. Recent Development
13.3 JCR Pharmaceuticals Co Ltd.
  13.3.1 JCR Pharmaceuticals Co Ltd. Company Details
  13.3.2 JCR Pharmaceuticals Co Ltd. Business Overview and Its Total Revenue
  13.3.3 JCR Pharmaceuticals Co Ltd. Hunter Syndrome Treatment Introduction
  13.3.4 JCR Pharmaceuticals Co Ltd. Revenue in Hunter Syndrome Treatment Business (2015-2020)
  13.3.5 JCR Pharmaceuticals Co Ltd. Recent Development
13.4 RegenxBio Inc.
  13.4.1 RegenxBio Inc. Company Details
  13.4.2 RegenxBio Inc. Business Overview and Its Total Revenue
  13.4.3 RegenxBio Inc. Hunter Syndrome Treatment Introduction
  13.4.4 RegenxBio Inc. Revenue in Hunter Syndrome Treatment Business (2015-2020)
  13.4.5 RegenxBio Inc. Recent Development
13.5 Sangamo Therapeutics, Inc.
  13.5.1 Sangamo Therapeutics, Inc. Company Details
  13.5.2 Sangamo Therapeutics, Inc. Business Overview and Its Total Revenue
  13.5.3 Sangamo Therapeutics, Inc. Hunter Syndrome Treatment Introduction
  13.5.4 Sangamo Therapeutics, Inc. Revenue in Hunter Syndrome Treatment Business (2015-2020)
  13.5.5 Sangamo Therapeutics, Inc. Recent Development
13.6 ArmaGen Inc.
  13.6.1 ArmaGen Inc. Company Details
  13.6.2 ArmaGen Inc. Business Overview and Its Total Revenue
  13.6.3 ArmaGen Inc. Hunter Syndrome Treatment Introduction
  13.6.4 ArmaGen Inc. Revenue in Hunter Syndrome Treatment Business (2015-2020)
  13.6.5 ArmaGen Inc. Recent Development
13.7 Inventiva S.A.
  13.7.1 Inventiva S.A. Company Details
  13.7.2 Inventiva S.A. Business Overview and Its Total Revenue
  13.7.3 Inventiva S.A. Hunter Syndrome Treatment Introduction
  13.7.4 Inventiva S.A. Revenue in Hunter Syndrome Treatment Business (2015-2020)
  13.7.5 Inventiva S.A. Recent Development
13.8 Denali Therapeutics Inc.
  13.8.1 Denali Therapeutics Inc. Company Details
  13.8.2 Denali Therapeutics Inc. Business Overview and Its Total Revenue
  13.8.3 Denali Therapeutics Inc. Hunter Syndrome Treatment Introduction
  13.8.4 Denali Therapeutics Inc. Revenue in Hunter Syndrome Treatment Business (2015-2020)
  13.8.5 Denali Therapeutics Inc. Recent Development
13.9 Bioasis Technologies Inc.
  13.9.1 Bioasis Technologies Inc. Company Details
  13.9.2 Bioasis Technologies Inc. Business Overview and Its Total Revenue
  13.9.3 Bioasis Technologies Inc. Hunter Syndrome Treatment Introduction
  13.9.4 Bioasis Technologies Inc. Revenue in Hunter Syndrome Treatment Business (2015-2020)
  13.9.5 Bioasis Technologies Inc. Recent Development
13.10 Esteve
  13.10.1 Esteve Company Details
  13.10.2 Esteve Business Overview and Its Total Revenue
  13.10.3 Esteve Hunter Syndrome Treatment Introduction
  13.10.4 Esteve Revenue in Hunter Syndrome Treatment Business (2015-2020)
  13.10.5 Esteve Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Hunter Syndrome Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Hunter Syndrome Treatment Revenue
Table 3. Ranking of Global Top Hunter Syndrome Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Hunter Syndrome Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Enzyme Replacement Therapy (ERT)
Table 6. Key Players of Hematopoietic Stem Cell Transplant (HSCT)
Table 7. Key Players of Others
Table 8. COVID-19 Impact Global Market: (Four Hunter Syndrome Treatment Market Size Forecast Scenarios)
Table 9. Opportunities and Trends for Hunter Syndrome Treatment Players in the COVID-19 Landscape
Table 10. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 11. Key Regions/Countries Measures against Covid-19 Impact
Table 12. Proposal for Hunter Syndrome Treatment Players to Combat Covid-19 Impact
Table 13. Global Hunter Syndrome Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 14. Global Hunter Syndrome Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 15. Global Hunter Syndrome Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 16. Global Hunter Syndrome Treatment Market Share by Regions (2015-2020)
Table 17. Global Hunter Syndrome Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 18. Global Hunter Syndrome Treatment Market Share by Regions (2021-2026)
Table 19. Market Top Trends
Table 20. Key Drivers: Impact Analysis
Table 21. Key Challenges
Table 22. Hunter Syndrome Treatment Market Growth Strategy
Table 23. Main Points Interviewed from Key Hunter Syndrome Treatment Players
Table 24. Global Hunter Syndrome Treatment Revenue by Players (2015-2020) (Million US$)
Table 25. Global Hunter Syndrome Treatment Market Share by Players (2015-2020)
Table 26. Global Top Hunter Syndrome Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hunter Syndrome Treatment as of 2019)
Table 27. Global Hunter Syndrome Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 28. Key Players Headquarters and Area Served
Table 29. Key Players Hunter Syndrome Treatment Product Solution and Service
Table 30. Date of Enter into Hunter Syndrome Treatment Market
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global Hunter Syndrome Treatment Market Size by Type (2015-2020) (Million US$)
Table 33. Global Hunter Syndrome Treatment Market Size Share by Type (2015-2020)
Table 34. Global Hunter Syndrome Treatment Revenue Market Share by Type (2021-2026)
Table 35. Global Hunter Syndrome Treatment Market Size Share by Application (2015-2020)
Table 36. Global Hunter Syndrome Treatment Market Size by Application (2015-2020) (Million US$)
Table 37. Global Hunter Syndrome Treatment Market Size Share by Application (2021-2026)
Table 38. North America Key Players Hunter Syndrome Treatment Revenue (2019-2020) (Million US$)
Table 39. North America Key Players Hunter Syndrome Treatment Market Share (2019-2020)
Table 40. North America Hunter Syndrome Treatment Market Size by Type (2015-2020) (Million US$)
Table 41. North America Hunter Syndrome Treatment Market Share by Type (2015-2020)
Table 42. North America Hunter Syndrome Treatment Market Size by Application (2015-2020) (Million US$)
Table 43. North America Hunter Syndrome Treatment Market Share by Application (2015-2020)
Table 44. Europe Key Players Hunter Syndrome Treatment Revenue (2019-2020) (Million US$)
Table 45. Europe Key Players Hunter Syndrome Treatment Market Share (2019-2020)
Table 46. Europe Hunter Syndrome Treatment Market Size by Type (2015-2020) (Million US$)
Table 47. Europe Hunter Syndrome Treatment Market Share by Type (2015-2020)
Table 48. Europe Hunter Syndrome Treatment Market Size by Application (2015-2020) (Million US$)
Table 49. Europe Hunter Syndrome Treatment Market Share by Application (2015-2020)
Table 50. China Key Players Hunter Syndrome Treatment Revenue (2019-2020) (Million US$)
Table 51. China Key Players Hunter Syndrome Treatment Market Share (2019-2020)
Table 52. China Hunter Syndrome Treatment Market Size by Type (2015-2020) (Million US$)
Table 53. China Hunter Syndrome Treatment Market Share by Type (2015-2020)
Table 54. China Hunter Syndrome Treatment Market Size by Application (2015-2020) (Million US$)
Table 55. China Hunter Syndrome Treatment Market Share by Application (2015-2020)
Table 56. Japan Key Players Hunter Syndrome Treatment Revenue (2019-2020) (Million US$)
Table 57. Japan Key Players Hunter Syndrome Treatment Market Share (2019-2020)
Table 58. Japan Hunter Syndrome Treatment Market Size by Type (2015-2020) (Million US$)
Table 59. Japan Hunter Syndrome Treatment Market Share by Type (2015-2020)
Table 60. Japan Hunter Syndrome Treatment Market Size by Application (2015-2020) (Million US$)
Table 61. Japan Hunter Syndrome Treatment Market Share by Application (2015-2020)
Table 62. Southeast Asia Key Players Hunter Syndrome Treatment Revenue (2019-2020) (Million US$)
Table 63. Southeast Asia Key Players Hunter Syndrome Treatment Market Share (2019-2020)
Table 64. Southeast Asia Hunter Syndrome Treatment Market Size by Type (2015-2020) (Million US$)
Table 65. Southeast Asia Hunter Syndrome Treatment Market Share by Type (2015-2020)
Table 66. Southeast Asia Hunter Syndrome Treatment Market Size by Application (2015-2020) (Million US$)
Table 67. Southeast Asia Hunter Syndrome Treatment Market Share by Application (2015-2020)
Table 68. India Key Players Hunter Syndrome Treatment Revenue (2019-2020) (Million US$)
Table 69. India Key Players Hunter Syndrome Treatment Market Share (2019-2020)
Table 70. India Hunter Syndrome Treatment Market Size by Type (2015-2020) (Million US$)
Table 71. India Hunter Syndrome Treatment Market Share by Type (2015-2020)
Table 72. India Hunter Syndrome Treatment Market Size by Application (2015-2020) (Million US$)
Table 73. India Hunter Syndrome Treatment Market Share by Application (2015-2020)
Table 74. Central & South America Key Players Hunter Syndrome Treatment Revenue (2019-2020) (Million US$)
Table 75. Central & South America Key Players Hunter Syndrome Treatment Market Share (2019-2020)
Table 76. Central & South America Hunter Syndrome Treatment Market Size by Type (2015-2020) (Million US$)
Table 77. Central & South America Hunter Syndrome Treatment Market Share by Type (2015-2020)
Table 78. Central & South America Hunter Syndrome Treatment Market Size by Application (2015-2020) (Million US$)
Table 79. Central & South America Hunter Syndrome Treatment Market Share by Application (2015-2020)
Table 80. Takeda Company Details
Table 81. Takeda Business Overview
Table 82. Takeda Product
Table 83. Takeda Revenue in Hunter Syndrome Treatment Business (2015-2020) (Million US$)
Table 84. Takeda Recent Development
Table 85. GC Pharma. Company Details
Table 86. GC Pharma. Business Overview
Table 87. GC Pharma. Product
Table 88. GC Pharma. Revenue in Hunter Syndrome Treatment Business (2015-2020) (Million US$)
Table 89. GC Pharma. Recent Development
Table 90. JCR Pharmaceuticals Co Ltd. Company Details
Table 91. JCR Pharmaceuticals Co Ltd. Business Overview
Table 92. JCR Pharmaceuticals Co Ltd. Product
Table 93. JCR Pharmaceuticals Co Ltd. Revenue in Hunter Syndrome Treatment Business (2015-2020) (Million US$)
Table 94. JCR Pharmaceuticals Co Ltd. Recent Development
Table 95. RegenxBio Inc. Company Details
Table 96. RegenxBio Inc. Business Overview
Table 97. RegenxBio Inc. Product
Table 98. RegenxBio Inc. Revenue in Hunter Syndrome Treatment Business (2015-2020) (Million US$)
Table 99. RegenxBio Inc. Recent Development
Table 100. Sangamo Therapeutics, Inc. Company Details
Table 101. Sangamo Therapeutics, Inc. Business Overview
Table 102. Sangamo Therapeutics, Inc. Product
Table 103. Sangamo Therapeutics, Inc. Revenue in Hunter Syndrome Treatment Business (2015-2020) (Million US$)
Table 104. Sangamo Therapeutics, Inc. Recent Development
Table 105. ArmaGen Inc. Company Details
Table 106. ArmaGen Inc. Business Overview
Table 107. ArmaGen Inc. Product
Table 108. ArmaGen Inc. Revenue in Hunter Syndrome Treatment Business (2015-2020) (Million US$)
Table 109. ArmaGen Inc. Recent Development
Table 110. Inventiva S.A. Company Details
Table 111. Inventiva S.A. Business Overview
Table 112. Inventiva S.A. Product
Table 113. Inventiva S.A. Revenue in Hunter Syndrome Treatment Business (2015-2020) (Million US$)
Table 114. Inventiva S.A. Recent Development
Table 115. Denali Therapeutics Inc. Business Overview
Table 116. Denali Therapeutics Inc. Product
Table 117. Denali Therapeutics Inc. Company Details
Table 118. Denali Therapeutics Inc. Revenue in Hunter Syndrome Treatment Business (2015-2020) (Million US$)
Table 119. Denali Therapeutics Inc. Recent Development
Table 120. Bioasis Technologies Inc. Company Details
Table 121. Bioasis Technologies Inc. Business Overview
Table 122. Bioasis Technologies Inc. Product
Table 123. Bioasis Technologies Inc. Revenue in Hunter Syndrome Treatment Business (2015-2020) (Million US$)
Table 124. Bioasis Technologies Inc. Recent Development
Table 125. Esteve Company Details
Table 126. Esteve Business Overview
Table 127. Esteve Product
Table 128. Esteve Revenue in Hunter Syndrome Treatment Business (2015-2020) (Million US$)
Table 129. Esteve Recent Development
Table 130. Research Programs/Design for This Report
Table 131. Key Data Information from Secondary Sources
Table 132. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Hunter Syndrome Treatment Market Share by Type: 2020 VS 2026
Figure 2. Enzyme Replacement Therapy (ERT) Features
Figure 3. Hematopoietic Stem Cell Transplant (HSCT) Features
Figure 4. Others Features
Figure 5. Global Hunter Syndrome Treatment Market Share by Application: 2020 VS 2026
Figure 6. Life Science Companies Case Studies
Figure 7. Research Institutes Case Studies
Figure 8. Hospital Case Studies
Figure 9. Hunter Syndrome Treatment Report Years Considered
Figure 10. Global Hunter Syndrome Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Hunter Syndrome Treatment Market Share by Regions: 2020 VS 2026
Figure 12. Global Hunter Syndrome Treatment Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Hunter Syndrome Treatment Market Share by Players in 2019
Figure 15. Global Top Hunter Syndrome Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hunter Syndrome Treatment as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Hunter Syndrome Treatment Revenue in 2019
Figure 17. North America Hunter Syndrome Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Hunter Syndrome Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Hunter Syndrome Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Hunter Syndrome Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Hunter Syndrome Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Hunter Syndrome Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Hunter Syndrome Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Takeda Total Revenue (US$ Million): 2019 Compared with 2018
Figure 25. Takeda Revenue Growth Rate in Hunter Syndrome Treatment Business (2015-2020)
Figure 26. GC Pharma. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. GC Pharma. Revenue Growth Rate in Hunter Syndrome Treatment Business (2015-2020)
Figure 28. JCR Pharmaceuticals Co Ltd. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. JCR Pharmaceuticals Co Ltd. Revenue Growth Rate in Hunter Syndrome Treatment Business (2015-2020)
Figure 30. RegenxBio Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. RegenxBio Inc. Revenue Growth Rate in Hunter Syndrome Treatment Business (2015-2020)
Figure 32. Sangamo Therapeutics, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. Sangamo Therapeutics, Inc. Revenue Growth Rate in Hunter Syndrome Treatment Business (2015-2020)
Figure 34. ArmaGen Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. ArmaGen Inc. Revenue Growth Rate in Hunter Syndrome Treatment Business (2015-2020)
Figure 36. Inventiva S.A. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. Inventiva S.A. Revenue Growth Rate in Hunter Syndrome Treatment Business (2015-2020)
Figure 38. Denali Therapeutics Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. Denali Therapeutics Inc. Revenue Growth Rate in Hunter Syndrome Treatment Business (2015-2020)
Figure 40. Bioasis Technologies Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 41. Bioasis Technologies Inc. Revenue Growth Rate in Hunter Syndrome Treatment Business (2015-2020)
Figure 42. Esteve Total Revenue (US$ Million): 2019 Compared with 2018
Figure 43. Esteve Revenue Growth Rate in Hunter Syndrome Treatment Business (2015-2020)
Figure 44. Bottom-up and Top-down Approaches for This Report
Figure 45. Data Triangulation
Figure 46. Key Executives Interviewed